Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?

Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?

Artificial intelligence (AI) is emerging as a discipline capable of providing significant added value in Medicine, in particular in radiomic, imaging analysis, big dataset analysis, and also for generating virtual cohort of patients. However, in coping with chronic myeloid leukemia (CML), considered...

Full description

Bibliographic Details
Main Authors: Simona Bernardi, Mauro Vallati, Roberto Gatta
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
chronic myeloid leukemia
artificial intelligence
machine learning
minimal residual disease
risk assessment
Online Access:https://www.mdpi.com/2072-6694/16/5/848

Internet

https://www.mdpi.com/2072-6694/16/5/848

Similar Items